South Korea Aesthetic Devices Market

The South Korea Aesthetic Devices Market was worth USD 325.0 million in 2025. The estimate covers professional aesthetic-device systems, directly associated consumables, leases and maintenance revenue earned within South Korea, while excluding injectable products, cosmetics, clinic procedure fees and manufacturers' export revenue. Supply-side company modelling, operational placement analysis and a provider-demand cross-check were weighted to produce the final estimate. Under the base forecast, the market is projected to reach USD 488.1 million by 2031 at a CAGR of 7.01%.

Growth is being driven by medical tourism, non-surgical treatment demand, an aging population, strong domestic engineering and recurring consumables. South Korea received 1,170,467 foreign patients in 2024, with dermatology accounting for approximately 705,000 visits. Korean clinics also adopt new HIFU, monopolar RF and microneedling RF platforms rapidly because treatment differentiation supports patient acquisition. Suppliers gain additional revenue from cartridges, tips, service contracts and replacement systems as clinic utilization and installed bases expand.

Energy-Based Aesthetic Devices are the dominant category because they serve high-volume applications including skin tightening, pigmentation, resurfacing, scar treatment, hair removal and body contouring. HIFU, RF, laser and light platforms accounted for an estimated 78% of market revenue in 2025. These devices also create recurring sales through cartridges, disposable tips and maintenance. Within the category, radiofrequency is expected to record the strongest growth as monopolar and microneedling RF protocols gain broader use.

Dermatology clinics generate the largest demand because they perform frequent outpatient procedures and can operate several platforms across multiple treatment rooms. Seoul's concentration of specialists and foreign patients supports high utilization and faster replacement cycles. Plastic-surgery clinics are important premium buyers, especially for combination protocols, while hospitals provide smaller volumes but strong clinical-reference value. Medical spas and hybrid clinics represent an emerging segment where physician oversight and flexible equipment financing are critical.

The top 10 suppliers accounted for an estimated 76.5% of South Korean market revenue in 2025. Classys, Cynosure Lutronic, Jeisys Medical, Wontech and Hironic formed the leading domestic-oriented group, while InMode, Solta, Candela, Alma and BTL competed through premium or differentiated technologies. Market concentration is moderated by a fragmented group of smaller domestic manufacturers, importers and specialist distributors that compete through price, niche indications and regional relationships.

Aesthetic medical devices require MFDS classification, authorization appropriate to device risk, Korean-language technical documentation and quality-system compliance. Importers and local manufacturers must maintain complaint, adverse-event and post-market processes. Production, import, export and repair performance for the prior year must be reported during January. Product modifications involving energy delivery, software, components or intended-use claims may require regulatory assessment, making lifecycle documentation and change control commercially important.

The strongest opportunities are RF microneedling, combination HIFU and RF protocols, managed-equipment contracts and expansion into regional medical-tourism centers. Busan and Jeju recorded foreign-patient growth of 133.6% and 221.0%, respectively, during 2024. Leasing and pay-per-use models can also expand adoption among smaller clinics that cannot support large upfront purchases. Suppliers able to connect equipment, consumables, training and patient-acquisition support can capture more value than firms selling standalone platforms.